tiprankstipranks
Trending News
More News >
Coherus Biosciences (CHRS)
NASDAQ:CHRS

Coherus Biosciences (CHRS) Revenue

Compare
1,637 Followers

Coherus Biosciences Revenue

Coherus Biosciences had a revenue of 11.57M in the quarter ending Sep 30, 2025, with 12.84%. This bring the company's revenue in the last twelve months to 83.57M, Increased -41.47%. In the fiscal year ending Dec 31, 2024, Coherus Biosciences had annual revenue of 266.96M with 3.78% growth.
Revenue (ttm)
83.57M
Revenue Growth
-72.54%
P/S Ratio
0.62
Revenue/Employee
$1,170,877
Employees
228
Market Cap
$164.38M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
266.96M9.72M+103.78%
Dec 31, 2023
257.24M46.20M+121.89%
Dec 31, 2022
211.04M-115.51M+64.63%
Dec 31, 2021
326.55M-149.27M+68.63%
Dec 31, 2020
475.82M119.75M+133.63%
Dec 31, 2019
356.07M354.51M+22,883.76%
Dec 31, 2018
1.56M0.00+100.00%
Dec 31, 2017
1.56M-188.55M+0.82%
Dec 31, 2016
190.11M